Biomedical progress will accelerate as we accumulate, and become more skillful with, tools like CRISPR and genomic sequencing, but the real rate-limiting factor

Biomedical progress will accelerate as we accumulate, and become more skillful with, tools like CRISPR and genomic sequencing, but the real rate-limiting factor in these developments is testing. Making sure a treatment performed on humans is safe is an extremely important and still very difficult process. Without innovation in that sphere we’re unlikely to see stem cells and co. generate a fraction of the possible advances, in the near future.